SBFM Stock Analysis: Buy, Sell, or Hold?
SBFM - Sunshine Biopharma Inc.
$2.66
0.06 (2.31%)
▲
5d:
+526.77%
30d:
+141.82%
90d:
+131.3%
WAIT
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When SBFM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
12 traders called SBFM this week
67% bullish • 4 bearish
67% bullish • 4 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: SBFM is 70.5% above its trading range ($1.56). Market expects -3.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: SBFM is 70.5% above its trading range ($1.56). Market expects -3.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.12
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.56
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBFM is currently trading at $2.66, which is considered extended relative to its 30-day fair value range of $0.30 to $1.56. The stock's valuation (Forward PE: 13.3) is in line with its historical norms (14.7). Remarkably, the market is currently pricing in an annual earnings decline of 3.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBFM is showing sideways momentum. Immediate support is located at $0.25, while resistance sits at $3.05.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $56.00 (+2005.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SBFM is showing sideways momentum. Immediate support is located at $0.25, while resistance sits at $3.05.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $56.00 (+2005.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.30 -
$1.56
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
36.7%
All Signals
- BEARISH: Price significantly overextended (+70.5% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: Trading 2005.3% below Wall St target ($56.00)
Trading Range Analysis
30-Day Trading Range
$0.30 -
$1.56
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.25
Resistance Level
$3.05
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.30
Wall Street Target
$56.00
(+2005.3%)
Revenue Growth (YoY)
-9.1%
Profit Margin
-17.0%
Valuation Discount vs History
-3.2% cheaper
PE vs Historical
13.3 vs 14.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.2%
(market-implied from PE analysis)
1-Year Target
$2.57
(-3%)
2-Year Target
$2.49
(-6%)
3-Year Target
$2.41
(-9%)
3-Yr Target (if PE normalizes)
(PE: 13→15)
$2.67
(+0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.3 to 14.7
Stabilization Target:
$2.94
(+10.5%)
PE Expansion Potential:
+10.5%
Share & Embed Analysis
Last updated: June 03, 2026 11:50 PM ET
Data refreshes hourly during market hours. Next update: 12:50 AM
Data refreshes hourly during market hours. Next update: 12:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBFM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$192 | 66 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 60 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 56 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 55 HOLD |
